Canaccord Genuity’s stock edges higher on solid trading volume, while routine regulatory filings confirm a compliant, resilient mid‑cap player ready for market upside.
Canaccord Genuity’s stock slides under 200‑day average, raising doubts about its global strategy amid fintech pressure. Investors await a turnaround plan.